Apart from the ongoing corporate earnings season, which investors are using as a gauge for the continent's economy, all eyes are on the sti...

Around 440 jobs will go in Switzerland and up to 240 in the United States over the next two to three years, the Basel-based company said. T...

Roche has announced its acquisition of Telavant, a developer of a new treatment for inflammatory bowel diseases, for an initial $7.1 billio...

The pool of family shareholders, who previously owned 45.01% of the voting rights in Roche, were given the exemption by the Swiss takeover ...

The approval was based on phase 3 trials finding that the antibody cocktail dramatically reduced the likelihood that mild or moderate Covid...

The query was posed to the government by Justice Prathiba M Singh after Roche India, which supplies Tocilizumab in India, told the court it...

The arrangement is the third transaction signed by Novartis following agreements with BioNTech and CureVac to make therapies for other firm...

According to the CIC, Roche Group is dominant in the relevant market and can operate independently of the market forces.

CYCLING ROAD-WORLD CHAMPIONSHIPS/RESULTS:Cycling-Road-World Championships results

Prime Minister Modi held wide-ranging talks with prominent business leaders from Switzerland including officials of ABB, Lafarge, Novartis,...

Roche Products (India) Private Ltd is a wholly owned subsidiary of the Switzerland based Roche Group and has products in therapeutic areas .

Pilatus is looking to set up a manufacturing facility in India for its PC-12 nine-seat airliner, a top company official said here.

Cipla says it has scored a "landmark" court win in a patent challenge launched by Switzerland's Roche Holding over its version of a lung-ca...

A takeover of Illumina would be Roche’s largest purchase since the $46.8 billion acquisition of Genentech Inc., completed in March 2009.

Daiichi Sankyo-owned Ranbaxy Laboratories has settled its patent dispute with Swiss major Roche for the latter’s drug valganciclovir sold u...

Roche Holding AG lowered the acquisition price by 2.8% and took the offer for the US cancer-drug developer directly to shareholders.

Europe’s drug regulating body on Wednesday recalled an HIV treatment made by Roche Holding because of contamination.